HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kawanishi, M. Search for Related Content PubMed PubMed Citation Articles by Kawanishi, M. Agricola Articles by Kawanishi, M.

Topoisomerase I and II activities are required for Epstein—Barr virus replication

Department of Microbiology, Faculty of Medicine, Kyoto University, Kyoto 606, Japan

The roles of topoisomerases I and II in Epstein—Barr virus (EBV) replication were investigated using Raji cells infected with EBV. The topoisomerase II inhibitor ellipticine inhibited the synthesis of EBV polypeptides at concentrations which did not affect total protein synthesis. Slot blot analysis of total cellular DNA showed that camptothecin and ellipticine inhibited replication of progeny EBV DNA in superinfected Raji cells at concentrations which did not inhibit synthesis of EBV early polypeptides prerequisite for EBV DNA replication. Analysis of the structure of EBV DNA termini demonstrated that both inhibitors affected the replicating EBV DNA. Gardella gel electrophoresis showed that both inhibitors affected the formation of the linear form of EBV DNA. However, restriction analysis of EBV DNA in superinfected Raji cells demonstrated that both inhibitors degraded neither endogenous nor exogenous EBV DNA. Cell viability was not affected by either inhibitor at the concentrations tested. These findings suggest that topoisomerase II is required for expression of the EBV genome and that both topoisomerases I and II are involved in replication of the EBV genome during the lytic phase of the life cycle. The effects of topoisomerase inhibitors on the circular form of EBV DNA during virus replication are discussed.

Received 11 December 1992; accepted 8 June 1993.

This article has been cited by other articles:

				Y. Wang, H. Li, Q. Tang, G. G. Maul, and Y. Yuan Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: Involvement of Host Cellular Factors J. Virol., March 15, 2008; 82(6): 2867 - 2882. [Abstract] [Full Text] [PDF]

				C.-P. Lee, J.-Y. Chen, J.-T. Wang, K. Kimura, A. Takemoto, C.-C. Lu, and M.-R. Chen Epstein-Barr Virus BGLF4 Kinase Induces Premature Chromosome Condensation through Activation of Condensin and Topoisomerase II J. Virol., May 15, 2007; 81(10): 5166 - 5180. [Abstract] [Full Text] [PDF]

				M. Lehtinen, P. Koskela, H. M. Ogmundsdottir, A. Bloigu, J. Dillner, M. Gudnadottir, T. Hakulinen, A. Kjartansdottir, M. Kvarnung, E. Pukkala, et al. Maternal Herpesvirus Infections and Risk of Acute Lymphoblastic Leukemia in the Offspring Am. J. Epidemiol., August 1, 2003; 158(3): 207 - 213. [Abstract] [Full Text] [PDF]

				S. J. Advani, R. R. Weichselbaum, and B. Roizman Herpes simplex virus 1 activates cdc2 to recruit topoisomerase IIalpha for post-DNA synthesis expression of late genes PNAS, April 15, 2003; 100(8): 4825 - 4830. [Abstract] [Full Text] [PDF]